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INTRODUCTION
Hypertension is one of the primary risk factors for cardiovas‑
cular diseases, including cerebrovascular accident or stroke,[1] and 
a major cause of disability and death.[2] The leading causes of mor‑
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ABSTRACT
Hypertension remains a major health problem worldwide considering the prevalence of morbidity and mortality. Plants remain a reliable source 
of efficacious and better tolerated drugs and botanicals. This study was designed to investigate the effect of the chemo‑profiled hydroethanolic 
leaf extract of Byrsocarpus coccineus in ethanol‑ and sucrose‑induced hypertension. Groups of rats were treated orally (p.o.) with distilled 
water (10 ml/kg), ethanol (35%; 3 g/kg), sucrose (5‑7%), and B. coccineus (100, 200, and 400 mg/kg), and nifedipine together with ethanol and 
sucrose separately for 8 weeks. At the end of the treatment period, blood pressure and heart rate of rats were determined. Blood was collected 
for serum biochemical parameters and lipid profile assessment, and the liver, aorta, kidney, and heart were harvested for estimation of in vivo 
antioxidants and malondialdehyde (MDA). Results obtained in this study showed that B. coccineus at the various doses administered reduced 
the systolic, diastolic, and arterial blood pressure elevated by ethanol and sucrose. Also, the extract reversed the reduction in catalase (CAT), 
reduced glutathione (GSH), glutathione peroxidase (GPx), and superoxide dismutase (SOD) induced by ethanol and sucrose. The level of MDA 
was reduced compared to the ethanol‑ and sucrose‑induced hypertensive group. With respect to lipid profile, administration of B. coccineus 
at the various doses reduced the levels of triglycerides, low‑density lipoprotein (LDL), cholesterol, and atherogenic indices, compared to the 
ethanol and sucrose groups. In conclusion the hydroethanolic leaf extract of B. coccineus exerted significant antihypertensive effect and this 
is probably related to the antioxidant property and improvement of lipid profile observed in this study.
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tality worldwide are ischemic heart disease and cerebrovascular 
accident or stroke,[3] and suboptimal blood pressure (BP) control 
has been identified as the third ranked factor for disability‑adjusted 
life years.[4] According to Pater,[5] changes in definition and clas‑
sification of BP levels make hypertension the most commonly 
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diagnosed condition in primary and secondary healthcare systems 
and projects the entity at the first place in terms of workload and 
prescribing cost. As of the year 2000, 972 million people were 
living with hypertension worldwide,[6] with the overall prevalence 
being 26.4% of the world’s population (26.6% male and 26.1% 
female).[7] It is estimated that this number will rise to 1.56 billion 
by the year 2025.[6] According to Kearney et al.,[7] the estimated 
number of hypertensives in developing countries outweighed 
that of developed countries by almost twofold (639 million in 
developing countries vs. 333 million in developed countries). 
Chockalingam et al.[6] reported that about two‑thirds of hyper‑
tensives live in low‑ and middle‑income countries, resulting in a 
huge economic burden. Despite the disturbing facts, studies have 
shown that early diagnosis and treatment of hypertension leads 
to better quality of life and increased longevity.[8] Conventional 
drugs used in the treatment of hypertension, either to reduce car‑
diac output or lower peripheral resistance, exhibit deleterious side 
effects including dry cough, hyperkalemia, angioneurotic edema 
[angiotensin converting enzyme (ACE) inhibitors], symptomatic 
hypotension, angio‑edema (angiotensin II receptor blockers), 
central nervous system (CNS) side effects, hypotension, sexual 
dysfunction, disturbance of lipid metabolism, rebound hyperten‑
sion (β‑blockers), ankle swelling, headaches, flushing (calcium 
channel blockers), hypokalemia, hyperuricemia, and hypergly‑
cemia (thiazide diuretics).[9] The search for new drugs, especially 
from natural products and majorly plants, is geared toward the 
development of more efficacious and better tolerated drugs.
Byrsocarpus coccineus Schum. and Thonn. (Connaraceae) 
is a shrub or liane of savanna thickets found across West Africa, 
which grows in the wild and is cultivated.[10] The plant, commonly 
called “crimson thyme,” is known locally in Nigeria as “Tsaami‑
yar‑kasa” (Hausa), “Oke‑abolo” (Igbo), “Onyankpe‑chi” (Idoma), 
Anune‑chigh (Tiv), and “Orikoteni” (Yoruba). Preparations of 
the leaves, roots, and whole plant are used for the treatment of 
earache, jaundice, and venereal diseases, as a sedative,[11] and 
for treating diarrhea, inflammation,[12] urogenital diseases,[13] and 
urinary problems.[10] Extracts of the plant have been reported to 
possess molluscidal,[14] uterotonic,[15] in vitro antioxidant,[16] an‑
timicrobial,[17,18] anti‑inflammatory,[19] hepaprotective and in vivo 
antioxidant,[20] and in vitro biological[21] activities.
This study was designed to investigate the effect of the 
chemo‑profiled hydroethanolic leaf extract of B. coccineus on 
alcohol‑ and sucrose‑induced hypertension in rats based on the 
reported antioxidant activity of the extract and the involvement 
of oxidative stress in the pathogenesis of hypertension.
MATERIALS AND METHODS
Plant material and extraction
The fresh leaves of B. coccineus were purchased from 
Oja‑Oba Market in Mushin LGA of Lagos State, Nigeria, in 
April 2011. Botanical identification and authentication was done 
by Prof. J. D. Olowokudejo of the Department of Botany and 
Microbiology, Faculty of Science, University of Lagos, Lagos, 
Nigeria and Mr. T. K. Odewo, a former Senior Superintendent of 
the Forestry Research Institute of Nigeria (FRIN), Ibadan, Nigeria. 
Voucher specimen (FHI 106623) was deposited in the herbarium 
of the institute.
The pulverized air‑dried leaves of B. coccineus were macer‑
ated in hydroethanol solution (1:1; 100 g/1500 ml). The liquid was 
decanted after 48 h and the filtrate was concentrated to dryness 
at 40°C under reduced pressure, giving a dark brown solid with a 
yield of 8.67%. The brownish dried extract was weighed and stored 
in an air‑tight sample bottle in the refrigerator at 4°C. The extract 
was reconstituted in distilled water to achieve the desired working 
concentrations just before administration to experimental animals.
Experimental animals
Albino mice and rats of either sex, weighing on average 15 g 
and 150 g, respectively, were obtained from the Laboratory Ani‑
mal Centre of the College of Medicine, University of Lagos. The 
experimental animals were kept in well‑ventilated hygienic com‑
partments maintained under standard environmental conditions 
(23°C‑25ºC, 12 h/12 h light/dark cycle) and were acclimatized for 
2 weeks before the start of experimental procedures. The animals 
were fed with standard rodent diet (Livestock Feed PLC, Lagos, 
Nigeria) and water ad libitum. The experimental procedures ad‑
opted were in accordance with the provisions of the Experimenta‑
tion Ethics Committee on Animal Use of the College of Medicine, 
University of Lagos and the United States National Academy of 
Sciences Guide for the Care and Use of Laboratory Animals.[22]
Phytochemical screening and high‑performance liquid 
chromatography fingerprint analysis
Phytochemical screening, consisting of simple chemical tests 
to detect the presence of phytochemicals in the hydroethanolic leaf 
extract of B. coccineus, was carried out according to the methods 
of Edeoga et al.[23]
Compositional analysis of the extract was done by high‑perfor‑
mance liquid chromatography (HPLC) using flavonoids as markers. 
A solution of 22.8 mg/2 ml MeOH: H2O (1:1) extract was prepared, 
filtered through a 0.45‑µm membrane filter, and injected into the 
HPLC column (RP‑18, 5 µm). The injected volume was separately 
20 and 40 µl (to give two separate HPLC chromatograms of the 
extract), flow rate was 0.8 ml/min, mobile gradient was 0.05% 
trifluoroacetic acid (TFA) in acetonitrile (ACN):0.05% TFA in 
water (gradient), and the run time was 70 min. The detection wave‑
length was 210‑400 nm and the column temperature was 28°C‑35oC.
The Fourier transform infrared (FTIR) spectra were studied 
under IR region 4000‑400 cm − 1 (using KBr) for the identification 
of functional groups in different classes of compounds present in 
the samples.
Acute toxicity study
A set of mice were divided into five groups of five animals 
each. The animals were fasted (food was withheld, but not water) 
for 12 h prior to the commencement of the experiment. The mice 
were treated with graded doses (50, 100, 200, 400, and 800 mg/kg) 
of the extract by intraperitoneal (i.p.) administration. Another 
set of animals was treated with graded doses of the extract up to 
10 g/kg in divided doses by oral (p.o.) route. The control group 
received distilled water (10 ml/kg). All experimental animals were 
closely observed for manifestation of toxic symptoms and behav‑
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ioral changes for 2 h post‑administration. Mortality in each group 
within 24 h was recorded and the surviving mice were observed 
for a further 14 days for signs of delayed toxicity. The LD50 was 
estimated using the log dose‑probit analysis method.[24]
Alcohol‑ and sucrose‑induced hypertension
Rats were divided into 11 groups of six animals each and were 
treated p.o. as outlined below:
• Group 1: Distilled water 10 ml/kg (normal control)
•  Group 2: 35% ethanol (3 g/kg/day; hypertensive control for 
the ethanol model)
• Group 3: 35% ethanol (3 g/kg/day) + B. coccineus 100 mg/kg
• Group 4: 35% ethanol (3 g/kg/day) + B. coccineus 200 mg/kg
• Group 5: 35% ethanol (3 g/kg/day) + B. coccineus 400 mg/kg
•  Group 6: 35% ethanol (3 g/kg/day) + nifedipine 10 mg/kg 
(standard group for the ethanol model)
•  Group 7: 5% sucrose for 4 weeks, 6% for the next 2 weeks, 
and 7% for the last 2 weeks (hypertensive control for the 
sucrose model)
• Group 8: Sucrose (5‑7%) + B. coccineus 100 mg/kg
• Group 9: Sucrose (5‑7%) + B. coccineus 200 mg/kg
•  Group 10: Sucrose (5‑7%) + B. coccineus 400 mg/kg
•  Group 11: Sucrose (5‑7%) + nifedipine 10 mg/kg (standard group 
for the sucrose model). Treatments were administered for 
8 weeks as outlined above and the animals were weighed every 
week.[25] At the end of the treatment period of 8 weeks, rats 
were weighed and anesthetized by i.p. injection of urethane 
(1.5 g/kg). The trachea was exposed and cannulated to ensure 
free and normal respiration. The femoral artery was exposed by 
dissection, and cannulated and flushed with 1 ml of heparinized 
saline. The cannulated femoral artery was used for the recording 
of BP and heart rate (HR) by connecting the arterial cannula 
to a calibrated Statham strain‑gauge transducer connected to a 
polygraph (Grass Polygraph E and M, Harvard Physiograph). 
After the determination of BP and HR, blood was withdrawn 
from each animal into plain sample bottles by cardiac puncture. 
Blood samples were centrifuged at 3000 rpm for 5 min and 
the serum was collected using sterile pipettes. Serum levels of 
total cholesterol, high density lipoprotein (HDL), low density 
lipoprotein (LDL), triglycerides (TG), urea, bilirubin, alanine 
aminotransferase (ALT), aspartate aminotransferase (AST), 
and alkaline phosphatase (ALP) were estimated using Roche 
and Cobas commercial kits and Roche/Hitachi 904 automated 
analyzer. After blood collection, the animals were sacrificed 
by cervical dislocation, dissected, and the heart, aorta, liver, 
and kidneys of each rat were harvested, homogenized, and 
appropriately treated for the determination of the levels of 
tissue protein,[26] catalase (CAT), reduced glutathione (GSH), 
superoxide dismutase (SOD), glutathione peroxidase (GPx), 
and malondialdehyde (MDA).[27]
Atherogenic indices were calculated using the method of 
Ikewuchi:[28]
Cardiac risk ratio (CRR) = total cholesterol ÷ HDL cholesterol
Atherogenic coefficient (AC) = (total cholesterol − HDL 
cholesterol) ÷ HDL cholesterol
Atherogenic index (AI) = log (TG ÷ HDL cholesterol)
Statistical analysis
Results are expressed as Mean ± standard error of mean (SEM) 
(n = 6). The data were analyzed using one‑way analysis of vari‑
ance (ANOVA) followed by Tukey’s multiple comparison test us‑
ing GraphPad Prism 5 software (GraphPad Software Inc., La Jolla, 
CA, USA). Results were considered significant when P < 0.05.
RESULTS
Phytochemical screening and HPLC fingerprint analysis
Preliminary phytochemical analysis revealed the presence of 
alkaloids, tannins, saponins, and cardiac glycosides.
The fingerprint chromatogram of the hydroethanolic extract of 
B. coccineus was established with reference to chlorogenic acid, 
daidzin, rutin, and quercetin [Figure 1a]. As shown in Figure 1b 
and c, the presence of chlorogenic acid, rutin, and quercetin was 
established in the extract. The relative amount of the flavonoids in 
B. coccineus was 1081.50, 1202.93, and 83.11 ng for chlorogenic 
acid, rutin and quercetin, respectively (sample concentration: 
22.8 mg/2 ml, injection volume: 40 µl).
The strong absorption band observed at 3500‑3000 cm−1 may 
be due to the presence of bonded O–H and/or N–H of alcohol or 
amine/amide, respectively [Figure 2].
In general, the extract is suggested to contain alcohols, amines/
amide, as well as compounds with conjugated double bond such 
as flavonoids, terpenes, or coumarins.
Acute toxicity
The hydroethanolic leaf extract of B. coccineus did not pro‑
duce any mortality when administered p.o. up to 10 g/kg. No vis‑
ible signs of delayed toxicity and mortality were observed when 
the animals were monitored for a further 14 days. In respect of the 
i.p. route, no deaths were recorded at the lowest dose of 50 mg/kg 
while mortality was 100% at the highest dose of 800 mg/kg. At 
the higher doses of 400 mg/kg and 800 mg/kg, animals manifested 
piloerection, sedation, and writhing. The LD50 for the i.p. route 
was estimated to be 288.40 mg/kg.
Alcohol‑ and sucrose‑induced hypertension
Effect of B. coccineus on BP and HR
Eight weeks of ethanol administration (35%; 3 g/kg/day, p.o.) 
caused significant increase in systolic BP (37.56%, P < 0.001), dia‑
stolic BP (51.52%, P < 0.001), and HR (20%, P < 0.05), compared 
to normal control. B. coccineus at different doses caused significant 
reduction in systolic and diastolic BP relative to the ethanol hy‑
pertensive control group. The dose of 100 mg/kg produced 47.79, 
58.61, 50.63, and 22.86% reduction in systolic BP, diastolic BP 
(P < 0.001), mean arterial pressure (MAP), and HR (P < 0.01), 
respectively, compared to the ethanol hypertensive control group. 
Reduction in these values was significantly higher (P < 0.001) than 
the 20.56% (P < 0.001) and 23.34% (P < 0.01) reduction elicited 
by nifedipine for systolic and diastolic BP, respectively [Table 1].
With regard to the sucrose‑induced hypertension model, 
8 weeks of sucrose administration (5‑7% w/v in drinking water) 
also caused significant increase in systolic (44.48%, P < 0.05) and 
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diastolic (52.90%, P < 0.001) BP, compared to the normal control 
group. The extract at the various doses caused significant reduction 
in systolic BP, diastolic BP, and MAP, compared to the sucrose 
hypertensive control group. Pronounced effect was observed at the 
dose of 100 mg/kg for systolic BP (42.71%, P < 0.001), diastolic 
BP (47.06%, P < 0.001), and MAP (42.78%, P < 0.01), compared 
to the sucrose hypertensive control group. The effect of the extract 
at the dose of 100 mg/kg was comparable and not significantly 
Figure 1. (a) HPLC chromatogram of standard flavonoids; hydroethanolic extract of B. coccineus (b) 20 µl and (c) 40 µl injection volumes
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different (P > 0.05) from the effect of nifedipine which elicited 
33.93, 45.80 (P < 0.001), and 41.50% (P < 0.01) reduction in 
systolic BP, diastolic BP, and MAP, respectively, compared to the 
sucrose hypertensive control group [Table 1].
Effect of B. coccineus on antioxidant indices and MDA level 
in liver, kidney, heart, and aorta tissues
In the liver tissues, administration of ethanol (35%; 3 g/kg/day) 
for 8 weeks caused significant reduction (P < 0.01, 0.001) in 
the levels of CAT, GSH, SOD, and GPx and significant in‑
crease (P < 0.001) in the level of MDA compared to the normal 
control group. B. coccineus, at doses of 100, 200, and 400 mg/kg, 
and nifedipine reversed the effect of ethanol administration by 
causing significant increase (P < 0.05, 0.01, and 0.001, respec‑
tively) in the levels of CAT, GSH, SOD, GPx, and protein and 
significant reduction (P < 0.05, 0.01, and 0.001) in the level of 
MDA relative to the ethanol hypertensive group. Pronounced ef‑
fects of the extract were observed at the dose of 400 mg/kg, except 
in the case of GSH and protein in which marked increments were 
observed at doses of 100 and 200 mg/kg, respectively. These effects 
were comparable and not significantly different (P > 0.05) from the 
effects of nifedipine [Table 2]. Sucrose (5‑7% w/v), administered 
for 8 weeks, caused significant reduction (P < 0.05, 0.01) in the 
levels of CAT, GSH, and GPx and significant increase (P < 0.001) 
in the level of MDA in liver tissues compared to the normal 
control group. The extract at the dose of 100 mg/kg significantly 
reduced (P < 0.001) the level of MDA and increased (P < 0.001) 
the level of protein relative to the sucrose group, while at the 
dose of 200 mg/kg, the extract significantly reversed the effect of 
sub‑chronic administration of sucrose by increasing the levels of 
CAT, GPx, and protein (P < 0.05, 0.01) and reducing the level 
of MDA (P < 0.001) compared to the sucrose group. At the dose 
of 400 mg/kg, the extract significantly increased the level of 
CAT (P < 0.01) and reduced the level of MDA (P < 0.001) relative 
to the sucrose group, as was also observed with nifedipine which 
further significantly increased the level of protein (P < 0.05). These 
effects were comparable and not significantly different (P > 0.05) 
from the effects of nifedipine, as was the case in the ethanol 
model [Table 2].
With regard to kidney tissues, administration of ethanol 
caused significant reduction (P < 0.001) in the levels of CAT, 
SOD, and GPx and increase in the level of MDA (P < 0.001) 
compared to the normal control group. B. coccineus (100, 200, and 
400 mg/kg) reversed the diminution in parameters produced by 
ethanol by causing significant increase (P < 0.05, 0.01, and 0.001, 
respectively) in the levels of CAT, GSH, SOD, GPx, and protein 
and reduction in the level of MDA (P < 0.001) compared to the 
ethanol hypertensive group. The extract at the dose of 100 mg/kg 
additionally caused significant increase (P < 0.05) in the level of 
protein compared to the ethanol group. Nifedipine also elicited 
significant increase (P < 0.01, 0.001) in the levels of CAT, GSH, 
SOD, and GPx and reduction in the level of MDA (P < 0.001) 
relative to the ethanol hypertensive control group. Marked effects 
were generally observed with the extract at the highest dose of 
400 mg/kg and these effects were comparable and not significantly 
different (P > 0.05) from those of nifedipine [Table 3]. As shown 
in Table 3, administration of sucrose elicited significant reduction 
(P < 0.05, 0.001) in the levels of CAT, GSH, SOD, and GPx and 
increase in the level of MDA (P < 0.001) compared to the normal 
control group. B. coccineus at the dose of 100 mg/kg produced 
significant increase in the levels of CAT and GPx (P < 0.05 and 
0.001, respectively) and reduction in the level of MDA (P < 0.001), 
while at the dose of 200 mg/kg, the extract caused significant in‑
crease in the levels of GPx and protein (P < 0.001) and reduction 
in the level of MDA (P < 0.001) compared to the ethanol group. 
At the dose of 400 mg/kg, the extract significantly increased the 
level of GPx (P < 0.001) and reduced the level of MDA (P < 0.001) 
relative to the ethanol group. Nifedipine significantly increased 
the levels of CAT, SOD, and GPx (P < 0.05, 0.001) and reduced 
the level of MDA (P < 0.001) compared to the ethanol hyperten‑
sive group. Pronounced effects were produced on CAT and MDA 
at the dose of 100 mg/kg, with these effects being significantly 
less (P < 0.001) and comparable (P > 0.05) relative to nifedipine, 
respectively. With respect to GPx and protein, pronounced effects 
comparable and not significantly different from those of nifedipine 
were produced at a dose of 200 mg/kg of the extract.
With respect to the heart tissues, significant reduction 
(P < 0.001) was observed in the levels of CAT, GSH, GPx, and 
Figure 2. FTIR spectra of hydroethanolic extract of B. coccineus ran under IR region 4000‑400 cm−1 (using KBr)
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Table 2. Effect of B. coccineus hydroethanolic leaf extract (BC) on liver level of antioxidants and malondialdehyde in ethanol‑ and sucrose‑induced hypertension in rats 
Group Ethanol model Sucrose model 
CAT 
(U/mg 
protein)
GSH 
(U/mg 
protein)
SOD 
(U/mg 
protein)
GPx 
(U/mg 
protein)
MDA 
(U/mg 
protein)
Protein 
(mg)
CAT 
(U/mg 
protein)
GSH 
(U/mg 
protein)
SOD 
(U/mg 
protein)
GPx 
(U/mg 
protein)
MDA 
(U/mg 
protein)
Protein 
(mg)
Normal control 30.59±0.77 1.26±0.30 4.77±0.14 1.57±0.12 0.008±0.001 43.46±1.33 30.59±0.77 1.59±0.49 4.77±0.14 1.57±0.12 0.008±0.001 43.46±1.33
Ethanol/Sucrose 9.56±1.46b 0.24±0.06b 0.89±0.17c 0.38±0.12c 0.420±0.104c 29.41±2.22 11.10±1.73b 0.18±0.01a 2.81±0.09 0.52±0.19b 0.205±0.036c 30.29±0.59
BC 100 mg/kg+Toxicant 20.87±4.73 1.62±0.31γ 3.03±0.82* 1.01±0.20α 0.016±0.004γ 55.74±7.39γ 24.56±3.86 0.85±0.15 3.63±0.74 1.14±0.26 0.008±0.001γ 66.16±8.22a,γ
BC 200 mg/kg+Toxicant 20.03±4.26 1.48±0.04γ 2.76±0.63** 1.06±0.19α 0.014±0.001γ 61.45±4.28γ, a 28.82±4.15β 0.55±0.03 4.47±0.56 1.35±0.13α 0.013±0.001γ 60.45±6.89β
BC 400 mg/kg+Toxicant 34.39±1.19γ 1.35±0.01β 4.36±0.08γ 1.18±0.06β 0.012±0.001γ 46.82±0.67α 28.84±1.70β 1.23±0.46 3.56±0.74 1.18±0.26 0.014±0.001γ 48.44±2.33
Nifedipine 10 mg/kg+Toxicant 35.64±0.04γ 1.44±0.04γ 5.65±0.71γ 1.33±0.04γ 0.012±0.001γ 48.82±0.37β 28.62±4.66β 1.37±0.34 4.84±0.81 1.13±0.06 0.009±0.003γ 52.10±4.61α
Values are mean±S.E.M. (n=5). aP<0.05, bP<0.01, cP<0.001 vs. control; αP<0.05, βP<0.01, γP<0.001 vs. ethanol/sucrose; *P<0.05, **P<0.01 vs. nifedipine (One‑way ANOVA followed by Tukey’s multiple 
comparison test), CAT: Catalase; GSH: Reduced glutathione; SOD: Superoxide dismutase; GPx: Glutathione peroxidase; MDA: Malondialdehyde
Table 3. Effect of B. coccineus hydroethanolic leaf extract (BC) on kidney level of antioxidants and malondialdehyde in ethanol‑ and sucrose‑induced hypertension in rats
Group Ethanol model Sucrose model
CAT 
(U/mg 
protein)
GSH 
(U/mg 
protein)
SOD 
(U/mg 
protein)
GPx 
(U/mg 
protein)
MDA 
(U/mg 
protein)
Protein 
(mg)
CAT 
(U/mg 
protein)
GSH 
(U/mg 
protein)
SOD 
(U/mg 
protein)
GPx 
(U/mg 
protein)
MDA 
(U/mg 
protein)
Protein 
(mg)
Normal control 33.09±2.21 0.84±0.21 4.04±0.66 1.52±0.10 0.006±0.001 46.41±1.08 33.09±2.21 1.68±0.44 4.04±0.68 1.52±0.10 0.006±0.001 46.41±1.07
Ethanol/Sucrose 6.36±1.11c 0.14±0.06 0.76±0.11c 0.06±0.01c 0.074±0.008c 33.86±1.20 9.95±0.07c 0.04±0.01a 0.68±0.08a 0.60±0.09c 0.048±0.003c 32.74±0.57
BC 100 mg/kg+Toxicant 24.67±2.64γ,* 0.48±0.14 3.72±0.42γ 1.36±0.08γ 0.015±0.002γ 56.19±6.53α 23.77±2.93α,*** 1.36±0.43 3.06±0.72 1.44±0.04γ 0.011±0.002γ 45.97±0.84
BC 200 mg/kg+Toxicant 21.37±2.49a,β,** 1.17±0.34β 1.73±0.25a,** 1.38±0.06γ 0.044±0.019a 46.47±8.12 17.76±3.59b,*** 0.82±0.22 2.43±0.58 1.57±0.07γ 0.017±0.001b,γ,* 82.70±13.12b,γ
BC 400 mg/kg+Toxicant 37.91±3.13γ 1.16±0.01β 4.95±0.72γ 1.39±0.08γ 0.013±0.001γ 45.40±0.44 20.07±3.82a,*** 1.13±0.33 3.07±0.61 1.39±0.09γ 0.018±0.002b,γ,* 52.82±2.60
Nifedipine 10 mg/kg+Toxicant 37.76±3.81γ 1.10±0.02β 4.32±0.12γ 1.70±0.22γ 0.012±0.001γ 41.69±0.22 43.32±3.18γ 0.60±0.27 4.04±1.04α 1.58±0.04γ 0.007±0.001γ 57.58±9.74
Values are mean±S.E.M. (n=5). aP<0.05, bP<0.01, cP<0.001 vs. control; αP<0.05, βP<0.01, γP<0.001 vs. ethanol/sucrose; *P<0.05, **P<0.01 vs. nifedipine (One‑way ANOVA followed by Tukey’s multiple 
comparison test), CAT: Catalase; GSH: Reduced glutathione; SOD: Superoxide dismutase; GPx: Glutathione peroxidase; MDA: Malondialdehyde
Table 1. Effect of B. coccineus hydroethanolic leaf extract (BC) on blood pressure and heart rate in ethanol‑ and sucrose‑induced hypertension in rats 
Parameters Normal 
control
Ethanol 
3 g/kg/day 
(%)
BC 
100 mg/kg+ 
Ethanol (%)
BC 
200 mg/kg+ 
Ethanol (%)
BC 
400 mg/kg+ 
Ethanol (%)
Nifedipine 
10 mg/kg+ 
Ethanol (%)
Sucrose 
5‑7% w/v 
(%)
BC 
100 mg/kg+ 
Sucrose (%)
BC 
200 mg/kg+ 
Sucrose (%)
BC 
400 mg/kg+ 
Sucrose (%)
Nifedipine 
10 mg/kg+ 
Sucrose (%)
SBP (mmHg) 96.90±4.06 133.30±5.64c 
(37.56) 
69.60±4.10b,γ,*** 
(47.79)
90.50±4.56γ 
(32.11)
116.80±3.45a 
(12.38)
105.90±5.86γ 
(20.56)
140.00±3.96a 
(44.48)
80.20±2.80γ 
(42.71)
82.70±4.60γ 
(40.93)
89.40±1.20γ 
(36.14)
92.50±7.57γ 
(33.93)
DBP (mmHg) 72.40±4.19 109.70±4.96c 
(51.52) 
45.40±3.46b,γ,*** 
(58.61)
68.90±5.22γ 
(37.19)
99.10±3.74b 
(9.66)
84.10±6.47β 
(23.34)
110.70±3.46c 
(52.90)
58.60±3.33γ 
(47.06)
60.00±4.98γ 
(45.80)
68.20±1.31γ 
(38.39)
60.00±7.65γ 
(45.80)
MAP (mmHg) 96.22±9.73 108.30±11.48 
(12.55)
53.47±7.81a,β 
(50.63)
76.10±10.37 
(29.73)
98.00±9.68 
(9.51)
85.17±14.89 
(21.36)
115.00±8.14 
(19.52)
65.80±5.42β 
(42.78)
67.50±10.28β 
(41.30)
75.47±2.40α 
(34.37)
67.28±9.47β 
(41.50)
HR (beat/min.) 350.00±18.44 420.00±0.00a 
(20.00)
324.00±14.70β 
(22.86)
360.00±0.00 
(14.29)
372.00±22.45 
(11.43)
372.00±22.45 
(11.43)
400.00±12.65 
(14.29)
372.00±12.00 
(7.00)
360.00±18.97 
(10.00)
324.00±30.59 
(19.00)
340.00±25.30 
(15.00)
Values are mean±S.E.M. (n=5‑6). aP<0.05, bP<0.01, cP<0.001 vs. normal control; αP<0.05, βP<0.01, γP<0.001 vs. ethanol/sucrose; ***P<0.001 vs. nifedipine (One‑way ANOVA followed by Tukey’s multiple 
comparison test)
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protein and increase was observed in the level of MDA (P < 0.001) 
in the ethanol hypertensive control group compared to the normal 
control rats. B. coccineus at doses of 100, 200, and 400 mg/kg and 
nifedipine elicited significant reduction in MDA and increase in 
GSH and protein levels (P < 0.001) compared to the ethanol group. 
In addition, the extract at the dose of 100 mg/kg significantly in‑
creased the level of SOD (P < 0.001) while there was a significant 
increase in the level of CAT (P < 0.001) at the dose of 400 mg/kg, 
compared to the ethanol group. Peak effects of the extract were 
produced at the dose of 100 mg/kg with respect to SOD, MDA, 
and protein and at the dose of 400 mg/kg for CAT and GSH. 
These effects of the extract were comparable and not significantly 
different (P > 0.05) from those of nifedipine, except in the case 
of SOD which was significantly higher (P < 0.001) [Table 4]. 
As presented in Table 4, sucrose significantly reduced (P < 0.05, 
0.001) the levels of CAT, GSH, SOD, GPx, and protein and 
increased the level of MDA (P < 0.001) relative to the normal 
control group. B. coccineus at doses of 100, 200, and 400 mg/kg 
and nifedipine significantly increased (P < 0.01, 0.001) the levels 
of GPx and protein and reduced the level of MDA (P < 0.01, 
0.001) compared to the sucrose hypertensive group. In addition, 
the extract at the dose of 400 mg/kg significantly increased the 
level of GSH (P < 0.05) while nifedipine further significantly 
increased the level of CAT, GSH, and SOD (P < 0.05, 0.001) rela‑
tive to the sucrose group. Pronounced effects were produced in the 
levels of MDA and protein at the extract dose of 200 mg/kg and 
in the levels of GSH and GPx at the extract dose of 400 mg/kg. 
The effect of the extract was significantly higher on the level of 
MDA (P < 0.01) and significantly lower (P < 0.001) on the level 
of GPx compared to nifedipine.
Considering the aorta, ethanol elicited significant 
(P < 0.01, 0.001) reduction in the levels of CAT, SOD, and protein 
while causing increase in MDA compared to the normal control 
group. B. coccineus (100, 200, and 400 mg/kg) and nifedipine 
reversed the effect of ethanol by causing significant increase 
(P < 0.05, 0.01, 0.001) in the levels of GSH, CAT, SOD, GPx and 
protein while reducing MDA compared to the ethanol hypertensive 
control group. Marked effect was obtained with the extract at 
the dose of 200 mg/kg for CAT, GSH, and SOD, and at the dose 
400 mg/kg for GPx, MDA, and protein. The most pronounced 
effects of the extract were comparable and not significantly dif‑
ferent (P > 0.05) from those of nifedipine, except for the effect 
of B. coccineus at 200 mg/kg on GSH and at 400 mg/kg on GPx 
which were significantly higher (P < 0.01, 0.001) than the values 
for nifedipine [Table 5]. Sucrose administration caused significant 
(P < 0.001) reduction in the levels of CAT, SOD, GPx, and protein, 
while causing increase in MDA compared to the normal control 
group. B. coccineus at doses of 100, 200, and 400 mg/kg caused 
significant increase (P < 0.05, 0.001) in the levels of GSH, GPx, 
protein, and CAT and reduction in the level MDA compared to 
the sucrose hypertensive group. Nifedipine caused significant 
increase (P < 0.001) in the levels of GPx and protein and reduc‑
tion in the level of MDA compared to the sucrose hypertensive 
group. Marked effects of the extract were observed at 400 mg/kg 
for CAT and GPx, at 200 mg/kg for GSH and protein, and at 
100 mg/kg for MDA. The most pronounced effects of the extract 
were comparable and not significantly different (P > 0.05) from 
the effects of nifedipine, except at the dose of 400 mg/kg for GPx 
which was significantly higher (P < 0.001) [Table 5].
Effect of B. coccineus on serum biochemical parameters
Eight weeks of administration of ethanol caused significant 
increase (P < 0.01, 0.001) in the levels of albumin, total choles‑
terol, and LDL compared to the normal control group. B. coccineus 
caused significant reduction in the levels of albumin (100 mg/kg, 
P < 0.05), total cholesterol (100‑400 mg/kg, P < 0.01, 0.001), 
LDL (100‑400 mg/kg, P < 0.001), TG (100 mg/kg, P < 0.05), and 
urea (100 and 200 mg/kg, P < 0.05) compared to the ethanol hyper‑
tensive group. Nifedipine elicited significant reduction in the levels 
of albumin (P < 0.05), total cholesterol (P < 0.05), HDL (P < 0.05), 
and LDL (P < 0.001) and increase in AST (P < 0.05) compared 
to the ethanol hypertensive group. The values for albumin 
(100‑400 mg/kg, P < 0.001) and TG (100 mg/kg, P < 0.05) were 
significantly lower than the corresponding values for nifedip‑
ine [Table 6].
As shown in Table 7, sucrose administration caused significant 
(P < 0.05, 0.01, 0.001) increase in albumin, total cholesterol, 
LDL, and TG and reduction in protein compared to the normal 
control group. The extract elicited significant reduction in the 
levels of total cholesterol (100‑400 mg/kg, P < 0.001), LDL 
(100‑200 mg/kg, P < 0.05), and TG (100‑200 mg/kg, P < 0.05, 
0.01) and increase in protein (100‑400 mg/kg, P < 0.001) compared 
to the sucrose hypertensive group. Nifedipine also reversed the 
effects of sucrose administration by causing significant reduction 
in the levels of total cholesterol (P < 0.01), LDL (P < 0.05), and 
TG (P < 0.05) and increase in protein (P < 0.001) relative to the 
sucrose hypertensive group. A significant increase (P < 0.05) in the 
level of AST was observed with nifedipine. The value for albumin 
at the extract dose of 400 mg/kg was significantly lower (P < 0.05), 
while that for protein at the extract dose of 100 mg/kg was sig‑
nificantly higher (P < 0.05) relative to the corresponding values 
for nifedipine.
Effect of B. coccineus on atherogenic indices
Ethanol increased the values of CRR, AC, and AI (3.19, 
2.19, and −0.10, respectively) compared to the normal control 
group (2.42, 1.42, and − 0.18, respectively). B. coccineus at doses 
of 100, 200, and 400 mg/kg reversed the ethanol‑induced increase 
in atherogenic indices except in respect of AI at the extract dose 
of 200 mg/kg. Pronounced effect was produced at the lowest 
dose of 100 mg/kg with values of 1.50, 0.50, and −0.52 for CRR, 
AC, and AI, respectively. Nifedipine did not reduce the values 
of the atherogenic indices relative to the ethanol hypertensive 
group [Figure 3].
Sucrose also increased the values of CRR, AC, and AI (3.87, 
2.87, and 0.16, respectively) compared to the normal control group 
(2.42, 1.42, and −0.18, respectively). The extract at doses of 100 
and 200 mg/kg reduced the atherogenic indices values, relative to 
the sucrose group. The values for CRR, AC, and AI at the dose of 
100 mg/kg were 1.48, 0.48, and −0.33, respectively. B. coccineus 
at the dose of 400 mg/kg did not reduce the value of the athero‑
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Table 5. Effect of B. coccineus hydroethanolic leaf extract (BC) on aorta level of antioxidants and malondialdehyde in ethanol‑ and sucrose‑induced hypertension in rats
Group Ethanol model Sucrose model
CAT 
(U/mg 
protein)
GSH 
(U/mg 
protein)
SOD 
(U/mg 
protein)
GPx 
(U/mg 
protein)
MDA (U/
mg 
protein)
Protein 
(mg)
CAT 
(U/mg 
protein)
GSH 
(U/mg 
protein)
SOD 
(U/mg 
protein)
GPx 
(U/mg 
protein)
MDA 
(U/mg 
protein)
Protein 
(mg)
Normal control 234.86±19.78 1.94±0.61 47.18±1.82 13.08±0.23 0.025±0.004 4.52±0.05 234.86±19.78 2.28±0.56 47.18±1.82 13.08±0.24 0.025±0.004 4.52±0.05
Ethanol/Sucrose 78.69±5.42b 0.31±0.13 14.88±1.16b 3.46±1.14 0.513±0.098c 1.22±0.24c 83.88±0.49c 0.07±0.00 14.64±0.22c 1.72±0.05c 0.853±0.043c 2.03±0.27c
BC 100 mg/kg+Toxicant 193.43±15.17 26.97±10.80b,β,** 29.32±2.20 11.03±1.20 0.081±0.025γ 2.54±0.62a,* 165.01±14.75 7.61±2.26α 30.17±1.39 12.24±0.66γ 0.047±0.016γ 5.30±0.21c
BC 200 mg/kg+Toxicant 326.33±42.90γ 27.96±3.22b,β,** 61.25±6.51β 30.97±5.82b,γ,** 0.116±0.032γ 2.29±0.62b,** 130.13±8.37a 8.07±2.131α 28.03±0.57 15.25±0.95γ 0.065±0.018γ 5.75±0.47c,γ
BC 400 mg/kg+Toxicant 249.68±37.06β 23.51±2.95a,α,* 45.41±8.92β 41.40±2.63c,γ,*** 0.028±0.002γ 4.48±0.13γ 195.02±44.84α 7.55±1.79α 34.42±5.06 21.88±1.73c,γ,*** 0.121±0.036γ 5.55±0.39a,γ
Nifedipine 
10 mg/kg+Toxicant
219.37±34.99α 1.38±0.02 48.79±4.31γ 15.30±1.59 0.023±0.006γ 4.36±0.19γ 142.61±7.21a 3.56±1.92 32.84±3.02 15.04±1.17γ 0.067±0.030γ 5.03±0.39γ 
Values are mean±S.E.M. (n=5). aP<0.05, bP<0.01, cP<0.001 vs. control; αP<0.05, βP<0.01, γP<0.001 vs. ethanol/sucrose; *P<0.05, **P<0.01 vs. nifedipine (One‑way ANOVA followed by Tukey’s multiple 
comparison test), CAT: Catalase; GSH: Reduced glutathione; SOD: Superoxide dismutase; GPx: Glutathione peroxidase; MDA: Malondialdehyde
Table 6. Effect of B. coccineus hydroethanolic leaf extract (BC)  on serum biochemical parameters in ethanol‑induced hypertension in rats
Group ALT 
(u/L)
Albumin 
(g/L) 
ALP 
(u/L)
Cholesterol 
(mol/L)
AST 
(u/L)
Creatinine 
(µmol/L)
HDL 
(mol/L)
LDL 
(mol/L)
TG 
(mol/L)
Protein 
(g/L)
Urea 
(mmol/L)
Normal control 63.54±25.75 7.84±0.96 130.38±21.22 1.74±0.16 200.10±42.57 44.37±2.84 0.72±0.12 0.22±0.04 0.48±0.09 56.52±3.70 7.84±0.97 
Ethanol (35%; 3 g/kg/day) 71.32±12.99 55.00±3.46c 93.54±1.47 4.02±0.27b 68.02±14.14 39.64±9.42 1.26±0.24 1.12±0.24c 1.00±0.19 23.46±6.60 13.96±6.34
B. coccineus 100 mg/kg+Ethanol 29.26±6.62 16.64±5.55α,*** 81.60±17.62 1.20±0.19γ 113.30±35.69 25.23±6.35 0.80±0.11 0.28±0.06γ 0.24±0.05α,* 42.54±9.14 3.28±0.80α
B. coccineus 200 mg/kg+Ethanol 135.10±52.28 23.80±5.11*** 113.60±22.02 1.79±0.79β 232.00±56.26 52.05±13.33 0.61±0.06* 0.26±0.04γ 0.70±0.23 41.98±8.69 4.16±0.67α
B. coccineus 400 mg/kg+Ethanol 57.58±8.19 23.44±4.78*** 128.30±28.61 1.69±0.22β 208.90±27.18 37.62±10.08 0.92±0.14 0.32±0.06γ 0.52±0.11 47.64±6.76 22.10±9.09
Nifedipine 10 mg/kg+Ethanol 51.72±5.11 35.98±1.61c,α 155.80±21.73 2.06±0.12α 348.02±104.20α 20.66±0.26 0.54±0.10α 0.26±0.02γ 0.94±0.05 36.70±0.80 28.71±6.60
Values are mean±S.E.M. (n=5). aP<0.05, bP<0.01, cP<0.001 vs. control; αP<0.05, βP<0.01, γP<0.001 vs. ethanol/sucrose; *P<0.05, **P<0.01 vs. nifedipine (One‑way ANOVA followed by Tukey’s multiple 
comparison test), ALT: Alanine aminotransferase, ALP: Alkaline phosphatase, AST: Aspartate aminotransferase, HDL: High density lipoprotein, LDL: Low density lipoprotein, TG: Triglycerides
Table 4. Effect of B. coccineus hydroethanolic leaf extract (BC) on heart level of antioxidants and malondialdehyde in ethanol‑ and sucrose‑induced hypertension in rats
Group Ethanol model Sucrose model
CAT 
(U/mg 
protein)
GSH 
(U/mg 
protein)
SOD 
(U/mg 
protein)
GPx 
(U/mg 
protein)
MDA 
(U/mg 
protein)
Protein 
(mg)
CAT 
(U/mg 
protein)
GSH 
(U/mg 
protein)
SOD 
(U/mg 
protein)
GPx 
(U/mg 
protein)
MDA 
(U/mg 
protein)
Protein 
(mg)
Normal control 91.27±5.87 1.48±0.03 13.92±0.78 4.32±0.26 0.006±0.002 45.74±1.27 91.27±5.87 1.48±0.37 13.92±0.78 4.32±0.26 0.006±0.002 45.74±1.27
Ethanol/Sucrose 8.79±0.41c,γ 0.13±0.05c 1.10±0.13 0.18±0.02c 0.438±0.084c 29.21±2.24c 7.76±1.68c 0.27±0.01a 0.48±0.07c 0.33±0.10c 0.106±0.002c 21.16±3.14c
BC 
100 mg/kg+Toxicant
20.65±1.91c,*** 1.37±0.11γ 68.44±8.65c,γ,*** 2.01±0.82a 0.014±0.003γ 51.28±2.19γ 34.60±10.56c,* 0.72±0.12 5.68±1.89a,* 1.89±0.18c,γ,*** 0.022±0.001γ,* 47.47±6.02γ
BC 
200 mg/kg+Toxicant
28.65±8.49c,** 1.11±0.12a,γ,* 4.36±1.78 2.11±0.68 0.020±0.006γ 44.21±0.48γ 35.71±9.33c,* 1.15±0.19 6.78±2.37a 1.57±0.21c,β,*** 0.011±0.001γ,** 59.40±5.86γ
BC 
400 mg/kg+Toxicant
51.83±3.83c,γ 1.53±0.03γ 8.26±0.69 1.18±0.02b,* 0.040±0.026γ 42.32±0.26γ 37.55±8.13c,* 1.51±0.39α 7.42±2.35 1.81±0.19c,γ,*** 0.016±0.001γ,** 43.41±0.88β
Nifedipine 
10 mg/kg+Toxicant
59.69±5.89b 1.45±0.03γ 15.37±1.29 3.94±0.68γ 0.011±0.002γ 45.02±1.16γ 68.73±3.42γ 1.58±0.28α 13.22±0.05γ 3.71±0.32γ 0.061±0.020c,β 47.51±0.82γ
Values are mean±S.E.M. (n=5). aP<0.05, bP<0.01, cP<0.001 vs. control; αP<0.05, βP<0.01, γP<0.001 vs. ethanol/sucrose; *P<0.05, **P<0.01 vs. nifedipine (One‑way ANOVA followed by Tukey’s multiple 
comparison test), CAT: Catalase; GSH: Reduced glutathione; SOD: Superoxide dismutase; GPx: Glutathione peroxidase; MDA: Malondialdehyde
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genic indices compared to the sucrose group. The standard drug, 
nifedipine, reversed sucrose‑induced increment in the values of 
CRR, AC, and AI (1.79, 0.79, and −0.15, respectively), but to a 
lesser extent compared to the effect of the extract at the dose of 
100 mg/kg [Figure 4].
DISCUSSION
According to the WHO, hypertension is the leading cause of 
cardiovascular mortality worldwide.[3,8] With epidemiological stud‑
ies revealing that hypertension is a “silent killer” with no warning 
signs[29‑31] and many developing countries transiting from infectious 
to degenerative chronic diseases,[32] the prevalence of hypertension 
is on the increase. As a clinical and major public health problem[2] 
which affects about one‑quarter of the world’s adult population, 
hypertension as a modifiable, preventable, and controllable risk 
factor has reached epidemic proportions.[6] The prevention of 
potential end‑organ damage including myocardial infarction, kid‑
ney failure, and cerebrovascular stroke[8] would depend on early 
diagnosis and timely appropriate interventions. According to Touyz 
et al.,[33] risk factors for hypertension include dietary habits, such as 
high sodium or low potassium intake, high alcohol consumption, 
low levels of physical activity, and overweight.
Figure 4. Effect of B. coccineus hydroethanolic leaf extract (BC) on 
atherogenic indices derived from the mean values of relevant parameters 
in sucrose‑induced hypertension in rats
Figure 3. Effect of B. coccineus hydroethanolic leaf extract (BC) on 
atherogenic indices derived from the mean values of relevant parameters 
in ethanol‑induced hypertension in rats
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In this study, hypertension was induced in rats by chronic 
administration of ethanol and sucrose. High consumption of 
salt, alcohol, and sugar has been shown to induce cardiovascular 
dysfunction, and therefore are the major contributory factors to 
hypertension.[25,34] Estruch and Coca[35] reported that ethanol has 
complex direct vascular effects, including basal constriction and 
prominent elastic lamellae fragmentation, which affect vessels’ 
elasticity, and that endothelial dysfunction due to ethanol may in‑
duce changes in the relaxant capacity of endothelium and decrease 
the release of nitric oxide. Vasdev et al.[36] demonstrated that intra‑
cellular Ca2+ in vascular smooth muscle preparation increases with 
ethanol, even in the presence of Ca2+ channel blockade. Alcohol 
reduces the level of ionized magnesium which causes the blood 
vessels to relax, whereas calcium ion has the opposite effect.[25]
Sucrose‑induced hypertension, caused due to chronic inges‑
tion of large amounts of the sugar, is associated with increased 
peripheral sympathetic activity,[25] and the cause–effect relationship 
between insulin perturbations and many hormonal disturbances, 
capable of elevating BP, has been demonstrated.[34] The presence 
of high concentrations of sucrose in the renal tubule causes kidney 
lesions, and sucrose produces an accumulation of lipid in the aorta 
leading to enhanced atherogenicity.[25] High sucrose ingestion in‑
creases blood platelet stickiness that may predispose to coronary 
thrombosis, and healthy subjects show a significant increase in 
the level of TG after intake of a high sucrose or fructose diet.[34]
High consumption of alcohol and sugar is associated with 
oxidative stress and increased level of free radicals, which have 
been reported to play an important role in the pathogenesis of 
arterial hypertension.[37] Therefore, the inhibition of lipid peroxida‑
tion induced cellular and tissue oxidative damage by antioxidants 
is beneficial in the treatment of associated conditions, including 
diabetes and hypertension.
In this study, the administration of ethanol and sucrose to ex‑
perimental rats for 8 weeks caused significant increase in systolic 
and diastolic BP, MAP, HR, and serum levels of albumin, choles‑
terol, LDL, and TG, and reduction in the levels of enzymatic and 
non‑enzymatic antioxidants in the liver, kidney, heart, and aorta, 
compared to the normal control group.
Higher doses of ethanol induce hypertension by depleting 
antioxidants and increasing oxidative tissue injury in rats, while 
chronic consumption of sucrose rapidly raises insulinemia which 
leads to insulin resistance and consequently hypertension.[25,38,39] 
Regarding the effect on HR, Bunag et al.[38] also previously reported 
hypertension associated with tachycardia in sucrose hypertensive 
group of animals. However, in contrast to the observation in this 
study, Resstel et al.[40] and Bilanda et al.[25] reported hypertension 
induced by chronic ethanol administration with no change in the 
HR of rats. The concurrent administration of B. coccineus with 
ethanol and sucrose in this study significantly prevented the rise in 
systolic and diastolic BP, MAP, and HR observed in hypertensive 
rats. With respect to lipid profile, in earlier studies, alcohol and 
sucrose feeding was found to significantly increase total choles‑
terol, TG, and AI.[25,41] According to Stevens et al.,[42] dyslipidemia 
enhances vascular resistance and leads to an increase of BP. In 
this study, B. coccineus intervention reversed the elevation in total 
cholesterol, LDL, and TG observed in the ethanol and sucrose 
hypertensive groups, suggesting improvement in lipid profile. 
According to Martirosyan et al.[43] and Ikewuchi,[28] atherogenic 
indices are strong indicators of the risk of heart disease, and the 
risk of developing cardiovascular disease increases with increases 
in the values of these indices and vice versa. In this study, B. coc-
cinues, especially at the lowest dose of 100 mg/kg, considerably 
reduced the value of the atherogenic indices (CRR, AC, and AI) 
relative to the ethanol and sucrose hypertensive groups. Nifedipine 
elicited a similar trend of effect in the sucrose model, but the effect 
of the extract at the dose of 100 mg/kg was more pronounced.
Development of cardiovascular dysfunction in alcohol‑ and 
sucrose‑induced hypertension has been linked with increase in 
reactive oxygen species (ROS) and alteration of antioxidant de‑
fense status,[44] and oxidative stress induces tissue damage leading 
to impairment of kidney and liver functions.[25] As observed in this 
study, B. coccineus administration significantly reversed reduction 
in the levels of enzymatic and non‑enzymatic antioxidants in liver, 
kidney, heart, and aorta induced by ethanol and sucrose. This sug‑
gests that enhancement of in vivo antioxidant activity is one of the 
possible mechanisms for the antihypertensive property observed 
with the hydroethanolic leaf extract of B. coccineus. This finding 
is supported by the previous report of hepatoprotective activity 
associated with the in vivo antioxidant activities of the extract.[20]
The phytochemical screening of the hydroethanolic leaf extract 
of B. coccineus in this study revealed the presence of alkaloids, 
tannins, saponins, and cardiac glycosides. It has been shown that 
the biological activities of alkaloids include hypolipidemic and 
hypoglycemic activities,[45,46] and saponins have been reported to 
assist in the prevention of cardiovascular diseases by lowering 
plasma cholesterol concentrations through the excretion of cho‑
lesterol directly or indirectly as bile acids.[28,47,48] HPLC fingerprint 
analysis revealed the presence of chlorogenic acid, rutin, and 
quercetin. Suzuki et al.[49] reported that chlorogenic acid attenuates 
hypertension and improves the endothelial function in spontane‑
ously hypertensive rats. In the study, dietary 5‑caffeoylquinic acid 
reduced oxidative stress and improved nitric oxide bioavailability 
by inhibiting excessive production of ROS in the vasculature. 
These actions resulted in the attenuation of endothelial dysfunc‑
tion, vascular hypertrophy, and hypertension in spontaneously 
hypertensive rats. In a study by Panchal et al.,[50] rutin ameliorated 
metabolic changes including abdominal fat pads and glucose 
tolerance, changes in hepatic and cardiovascular structure and 
function, oxidative stress and inflammation in the liver and heart, 
and expression of liver markers induced by high‑carbohydrate, 
high‑fat diet. Based on the results obtained in the study, the authors 
suggested a non‑nutritive role for rutin to attenuate chronic changes 
in metabolic syndrome (obesity, diabetes, and hypertension). Egert 
et al.[51] investigated the effects of quercetin supplementation on 
BP, lipid metabolism, markers of oxidative stress, inflammation, 
and body composition in an at‑risk population of 93 overweight or 
obese subjects aged 25‑65 years with metabolic syndrome traits. 
Findings in the study revealed that quercetin reduced systolic BP 
and plasma oxidized LDL concentrations in overweight subjects 
with a high cardiovascular disease risk phenotype, suggesting that 
quercetin may provide protection against cardiovascular disease. 
The presence of these phenolic compounds and other bioactive 
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phytocomponents in B. coccineus extract may be responsible for 
the observed biological effects in this study. Further studies are 
required to isolate, identify, and characterize the specific principles 
and the precise mechanisms of action responsible for the antihy‑
pertensive activity produced by the hydroethanolic leaf extract of 
B. coccineus in this study.
With regard to acute toxicity, B. coccineus did not induce 
lethality in mice when administered p.o. up to 10 g/kg. It can, 
therefore, be said to be safe when administered orally, according 
to the assertion of Clarke and Clarke,[52] that a substance that does 
not produce lethality up to 10 g/kg orally is relatively non‑toxic. 
This fact is corroborated by the fact that there were no mortality 
and visible signs of delayed toxicity when animals were observed 
for a further 14 days. However, the LD50 administered intraperi‑
toneally was estimated to be 288.40 mg/kg.
CONCLUSION
The results obtained in this study suggest that the hydroethano‑
lic leaf extract of B. coccineus possesses antihypertensive activity 
possibly due to antioxidant activity and improvement in lipid pro‑
file. The observed biological actions may be due to the presence 
of phenolic compounds and other phytocomponents identified in 
the plant extract. Further studies are required to isolate, identify, 
and characterize the active phytoconstituents and determine the 
precise mechanism(s) of action.
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